Regional

Heart drug added to PBS subsidy list

Kalgoorlie Miner February 22, 2012, 9:42 am

A heart attack prevention drug will be listed on the Pharmaceutical Benefits Scheme at a cost of $100 million over five years.

The drug, Ticagrelor (trading as Brilinta), is used to treat myocardial infarction or unstable angina and can prevent heart attacks and blood clots.

The Federal Government also said other drugs to treat leukaemia, juvenile arthritis and high blood pressure are expected to be added to the PBS list in coming months.

The Government will increase the price of 17 medicines now on the PBS, following a recommendation by the Pharmaceutical Benefits Pricing Authority.


Follow thewest.com.au on Twitter

Explore More

  1. Inflammation could be key to treatment

  2. Play Video

    Federal government urges airport rethink

  3. Teens struggle to control diabetes

  4. Play Video

    Federal Government to hand out more

  5. High blood pressure affects 1 in 3: WHO

  6. Play Video

    Federal government looks to tax imports

  7. Heart care a lifelong affair

  8. Heart Attack Grill claims another victim

  9. Australia drought-free for first time in decade

[Change Location]

Perth

Currently

7.9°

Today's forecast: Sunny

6° - 24°

7 day forecast »

Most Viewed

  1. Finnish rooftop gunman seems not to be extremist
  2. The world's most epic marriage proposal?
  3. No foreigners in Aussie mining jobs: PM
  4. Centuries old bible 'mean Christianity's downfall'
  5. Pensioner left hanging by a thread in skydive
  6. Fury as thousands bid for mining jobs
  7. Coldest May morning in 98 years
  8. Man enters hospital for kidney stone, leaves a woman
  9. Two separate attacks wound five in north east Kenya
  10. Corby out by 2017 at the latest: official

Breaking

More Breaking News »
COMPARE & SAVE

Saving Accounts

COMPARE MORE

Credit Cards

COMPARE MORE

Home Loans

COMPARE MORE

iPhone 4S Cheapest Plans

COMPARE MORE

The West News Preferences

Close

Select your state to see news for your area.